Jay Backstrom
Chief Executive Officer at SCHOLAR ROCK HOLDING CORPORATION
Net worth: 6 M $ as of 31/03/2024
Profile
Presently, Jay T. Backstrom occupies the position of Executive VP & Head-Research & Development at Acceleron Pharma, Inc. He is also on the board of Autolus Therapeutics Plc. In his past career he held the position of Medical Director of Samuel U. Rodgers Community Health Center, Inc., Chief Medical Officer for Celgene Corp., Executive Director-Medical & Scientific Services at Quintiles, Inc. (California) and Vice President-Global Medical & Safety at Pharmion Corp. He received a doctorate from Temple University School of Medicine and a graduate degree from St Louis University School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/02/2024 | 352,671 ( 0.45% ) | 6 M $ | 31/03/2024 | |
DISC MEDICINE, INC.
-.--% | 14/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Jay Backstrom active positions
| Companies | Position | Start |
|---|---|---|
| LAVA THERAPEUTICS N.V. | Director/Board Member | 15/06/2022 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Executive Officer | 20/09/2022 |
Be Biopharma, Inc.
 Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Director/Board Member | 16/12/2021 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Director/Board Member | 01/12/2021 |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Director/Board Member | 01/07/2023 |
Former positions of Jay Backstrom
| Companies | Position | End |
|---|---|---|
| DISC MEDICINE, INC. | Director/Board Member | 09/06/2023 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 28/02/2023 |
| ACCELERON PHARMA INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
| CELGENE | Chief Tech/Sci/R&D Officer | 01/11/2019 |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Jay Backstrom
| St Louis University School of Public Health | Graduate Degree |
| Lewis Katz School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| LAVA THERAPEUTICS N.V. | Health Technology |
| DISC MEDICINE, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
| Samuel U. Rodgers Community Health Center, Inc. | |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA. | Health Services |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Commercial Services |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jay Backstrom
